For Proteomics, 2014 Marked by Interest, Critiques from the Broader Community | GenomeWeb

NEW YORK (GenomeWeb) – From scientific collaborations to corporate acquisitions, 2014 was a year in which proteomics drew significant interest from the broader scientific community, with the attention serving to highlight the field's capabilities and potential as well as its current limitations. 

Perhaps most notably, 2014 saw the rise of proteogenomics, with a number of researchers combining proteomic and genomic experiments with the aim of shedding light on both levels of data.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.